TickerFacts.

Company research / AORT

Artivion, Inc. (AORT)

Build a valuation ↗↓ Download CSV

SEC name ARTIVION, INC. · CIK 0000784199 · NYSE · Surgical & Medical Instruments & Apparatus

  • Sector Manufacturing
  • Incorporated DE
  • Fiscal year ends Dec 31

For the year ended 2025-12-31, Artivion, Inc. reported revenue of $441.33M. Revenue grew 13.6% from the prior annual period. Over the twelve months to 2026-06-30, revenue was $471.47M.

Key ratios (year ended 2025-12-31)

64.4%
Gross margin
7.6%
Operating margin
2.2%
Net margin
2.2%
Return on year-end equity
13.6%
Revenue growth (YoY)

Beyond the statements

Follow the company.

Explore new filings, reported insider transactions and company relationships.

Open company research ↗

Latest selected filing: Form 4 (ownership change) · 2026-09-11

Headquarters locality: Kennesaw · View on map

Annual financials

Annual flows and balances are grouped by their actual period end. Select a figure to open its SEC filing. n/a means a matching observation is unavailable. Free cash flow is operating cash flow minus capital expenditures, and EBITDA is operating income plus depreciation and amortization, for the same period, computed by TickerFacts.

The first column covers the twelve months to 2026-06-30 from the latest quarterly report: flows are the last fiscal year plus this year to date minus the same months a year earlier, and balances are as of that date. Per-share figures are annual only.

Period endedTTM to
2026-06-30		2025-12-312024-12-312023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-31
Revenue$471.47M$441.33M$388.54M$354.00M$313.79M$298.84M$253.23M$276.22M$262.84M$189.70M$180.38M
Cost of Revenue$167.97M$157.10M$139.76M$124.83M$111.27M$101.32M$85.44M$93.21M$89.86M$61.06M$61.48M
Gross Profit$303.50M$284.23M$248.78M$229.18M$202.52M$197.51M$167.78M$183.01M$172.98M$128.64M$118.90M
R&D Expense$35.10M$30.99M$28.45M$28.71M$38.88M$35.55M$24.21M$22.96M$23.10M$19.46M$13.45M
Operating Income$20.64M$33.74M$38.87M$5.74M$6.20M$8.12M$2.44M$17.04M$9.31M$7.97M$21.82M
Depreciation & Amortization$24.56M$22.46M$24.20M$23.08M$22.44M$23.98M$20.71M$18.32M$18.09M$9.74M$8.38M
EBITDA$45.20M$56.20M$63.08M$28.82M$28.64M$32.09M$23.15M$35.36M$27.41M$17.71M$30.20M
Net Income-$3.17M$9.77M-$13.36M-$30.69M-$19.19M-$14.83M-$16.68M$1.72M-$2.84M$3.70M$10.78M
EPS (Diluted)n/a$0.21-$0.32-$0.75-$0.48-$0.38-$0.44$0.05-$0.08$0.11$0.32
Total Assets$1.07B$884.80M$789.10M$792.40M$762.80M$793.05M$789.40M$605.65M$571.09M$589.69M$316.14M
Total Liabilities$626.35M$436.56M$512.90M$510.62M$478.47M$492.32M$460.69M$319.96M$296.02M$312.63M$107.16M
Long-Term Debt$363.42M$215.11M$314.35M$306.98M$308.11M$309.12M$291.66M$215.74M$216.88M$218.95M$71.57M
Shareholders' Equity$445.58M$448.23M$276.20M$281.78M$284.33M$300.73M$328.71M$285.70M$275.07M$277.06M$208.98M
Cash & Equivalents$77.32M$64.91M$53.46M$58.94M$39.35M$55.01M$61.41M$33.77M$41.49M$39.98M$56.64M
Operating Cash Flow$41.71M$39.88M$22.24M$18.82M-$5.15M-$2.58M$12.37M$15.83M$9.88M$10.80M$19.72M
Capital Expenditures$50.87M$39.04M$11.19M$9.75M$10.71M$13.09M$7.33M$8.07M$5.79M$6.63M$6.20M
Free Cash Flow-$9.16M$839.0K$11.05M$9.07M-$15.87M-$15.68M$5.04M$7.75M$4.09M$4.17M$13.52M
Dividends Per Sharen/an/an/an/an/an/an/a$0.00$0.00$0.00$0.00
Weighted Average Diluted Sharesn/a47.16M41.68M40.74M40.03M38.98M37.86M37.86M36.41M34.16M32.82M
EPS (Basic)n/a$0.22-$0.32-$0.75-$0.48-$0.38-$0.44$0.05-$0.08$0.11$0.33

Price chart

Chart and quotes by TradingView. Exchange coverage and delays vary.

Open chart on TradingView